Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure of Cadherins01:25

Structure of Cadherins

The cadherins were one of the first cell adhesion molecules discovered; the term “cadherins”   is based on their calcium-dependent adhering properties. The first cadherins discovered on the epithelial, neuronal, and placental cells were named E-cadherin, P-cadherin, and N-cadherin, respectively. These classical cadherins share sequence and structural similarities. Other cadherins, including those involved in cell signaling, are grouped into non-classical cadherins. This diversity of cadherins...
Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Clathrin Coated Vesicles01:12

Clathrin Coated Vesicles

Clathrin-coated vesicles use endocytosis to transport receptors and lysosomal hydrolases from the Golgi to the lysosome in the late secretory pathway. Clathrin-mediated endocytosis was the first described endocytic process, and Clathrin-coated vesicles remain one of the most well-studied transport vesicles. The molecular machinery that generates clathrin-coated vesicles comprises over 50 proteins that precisely coordinate vesicle formation. Cell surface receptors concentrated in indented sites...
Catenins01:23

Catenins

Catenins are characterized by multiple binding domains and dynamic structures that allow them to function as linker proteins in cell junction complexes. All catenins, except α-catenin, contain a characteristic protein sequence called the armadillo repeat and are therefore also called armadillo proteins.
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Protein Complexes with Interchangeable Parts01:57

Protein Complexes with Interchangeable Parts

Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models.

Research square·2021
Same author

Unique lamina propria stromal cells imprint the functional phenotype of mucosal dendritic cells.

Mucosal immunology·2014
Same author

The crystal structure of CD8 in complex with YTS156.7.7 Fab and interaction with other CD8 antibodies define the binding mode of CD8 alphabeta to MHC class I.

Journal of molecular biology·2008
Same author

PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment.

Neurology·2007
Same author

Voxel-based analysis of PET amyloid ligand [11C]PIB uptake in Alzheimer disease.

Neurology·2006
Same author

Crystal structure of the TCR co-receptor CD8alphaalpha in complex with monoclonal antibody YTS 105.18 Fab fragment at 2.88 A resolution.

Journal of molecular biology·2006

Related Experiment Video

Updated: Jul 14, 2026

A Method For Production of Recombinant mCD1d Protein in Insect Cells.
09:41

A Method For Production of Recombinant mCD1d Protein in Insect Cells.

Published on: December 10, 2007

Architecture of CD1 proteins.

D M Zajonc1, I A Wilson

  • 1Department of Molecular Biology, Skaggs Institute of Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.

Current Topics in Microbiology and Immunology
|June 28, 2007
PubMed
Summary

The CD1 family of cell surface receptors presents lipid antigens to T cells. Structural differences in how CD1 group 1 and group 2 present lipids impact T cell activation and drug design.

Area of Science:

  • Immunology
  • Structural Biology
  • Biochemistry

Background:

  • The CD1 family of glycosylated cell surface receptors plays a crucial role in presenting lipid antigens to T cells.
  • Understanding the structural basis of CD1-lipid interactions is key to deciphering T cell recognition and activation pathways.

Purpose of the Study:

  • To elucidate the distinct structural mechanisms by which CD1 group 1 and group 2 isoforms present lipid antigens.
  • To investigate ligand-induced conformational changes in CD1 molecules upon antigen binding.

Main Methods:

  • X-ray crystallography was employed to determine the structures of CD1-lipid complexes.
  • Comparative structural analysis of CD1 group 1 (CD1a, CD1b, CD1c) and group 2 (CD1d) isoforms bound to various lipid antigens.

More Related Videos

Ligand Nano-cluster Arrays in a Supported Lipid Bilayer
10:34

Ligand Nano-cluster Arrays in a Supported Lipid Bilayer

Published on: April 23, 2017

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation
12:09

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation

Published on: February 28, 2019

Related Experiment Videos

Last Updated: Jul 14, 2026

A Method For Production of Recombinant mCD1d Protein in Insect Cells.
09:41

A Method For Production of Recombinant mCD1d Protein in Insect Cells.

Published on: December 10, 2007

Ligand Nano-cluster Arrays in a Supported Lipid Bilayer
10:34

Ligand Nano-cluster Arrays in a Supported Lipid Bilayer

Published on: April 23, 2017

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation
12:09

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation

Published on: February 28, 2019

Main Results:

  • CD1 group 1 isoforms anchor the lipid backbone within hydrophobic grooves, while CD1d (group 2) positions polar headgroups via hydrogen bonding.
  • CD1d exhibits ligand-induced conformational changes upon binding of alpha-galactosylceramide, involving polar interactions with helices.
  • No significant ligand-induced conformational changes were observed for group 1 CD1 complexes with diverse lipid antigens.

Conclusions:

  • Distinct structural modes of lipid presentation by CD1 isoforms dictate T cell recognition.
  • Ligand-induced conformational changes in CD1d offer insights into invariant NKT cell activation.
  • Structural data facilitate the rational design of novel immunomodulatory agents and therapeutics for immune-mediated diseases.